SBE-β-CD [182410-00-0]

Referência M4837-1g

Tamanho : 1g

Marca : AbMole Bioscience


All AbMole products are for research use only, cannot be used for human consumption.

SBE-β-CD Structure
Synonym:

Sulfobutylether-β-Cyclodextrin; Sulfobutylether beta-cyclodextrin


Quality Control & Documentation
Biological Activity

SBE-β-CD (Sulfobutylether beta-cyclodextrin) is a unique reproducible mixture of polyanionic β-cyclodextrin derivatives in which a sodium sulfonate salt is tethered to the lipophilic cyclodextrin cavity by a butyl ether group, or sulfobutylether (SBE). The sulfobutyl ether (SBE) substituent is introduced at the 2, 3, and 6 positions in one or more of the glucopyranose units in the cyclodextrin structure. 

Product Citations
  • Patent. US12303531B2 2025-05-20.

    Patent. US12303531B2
    SBE-β-CD purchased from AbMole

  • Patent. US12303531B2 2025 May 20; .

    Patent. US12303531B2
    SBE-β-CD purchased from AbMole

  • Cell Rep. 2023 Jun 27;42(7):112690.

    Identification of XAF1 as an endogenous AKT inhibitor
    SBE-β-CD purchased from AbMole

  • Int J Mol Sci. 2023 Feb 6;24(4):3229.

    The Role of the Dopamine System in Post-Stroke Mood Disorders in Newborn Rats
    SBE-β-CD purchased from AbMole

  • The American Journal of Pathology. 2022 Dec.

    EZH2 Promotes Cholangiocarcinoma Development and Progression through Histone Methylation and microRNA-Mediated Down-Regulation of Tumor Suppressor Genes
    SBE-β-CD purchased from AbMole

  • Anal Cell Pathol (Amst). 2022 Oct 5;2022:3770715.

    Chemoprevention of 4NQO-Induced Mouse Tongue Carcinogenesis by AKT Inhibitor through the MMP-9/RhoC Signaling Pathway and Autophagy
    SBE-β-CD purchased from AbMole

  • Patent. AU2019358428B2 2022 Aug 04.

    Patent. AU2019358428B2
    SBE-β-CD purchased from AbMole

  • Patent. US2022267148A1 2022-08-25.

    Patent. US2022267148A1
    SBE-β-CD purchased from AbMole

  • Patent. US2022267148A1 2022 Aug 25; .

    Patent. US2022267148A1
    SBE-β-CD purchased from AbMole

  • Patent. EP3894446A1 2021 Oct 20.

    Patent. EP3894446A1
    SBE-β-CD purchased from AbMole

  • Patent. CA3114031A1 2020 Apr 16.

    Patent. CA3114031A1
    SBE-β-CD purchased from AbMole

  • Int J Cancer. 2013 Nov;133(9):2065-76.

    Combined targeting of AKT and mTOR using MK-2206 and RAD001 is synergistic in the treatment of cholangiocarcinoma.
    SBE-β-CD purchased from AbMole

Customer Product Validations & Biological Datas
Source J Biomed Mater Res B Appl Biomater (2016). Figure 3. Captisol
Method Transmission electron microscopy
Cell Lines MRC-5 cells
Concentrations 1 μM
Incubation Time 24 h
Results Deionized water-dispersed ICG, SCyD, and MCyD showed a size distribution ranging from 2 to 200 nm.
Source J Biomed Mater Res B Appl Biomater (2016). Figure 1. Captisol
Method Fluorescence
Cell Lines
Concentrations 10 mM
Incubation Time 24 h
Results Over 24 h, ICG retained just 0.383 of its initial fluorescence in water, while MCyD-I and SCyD-I in water retained 1.943 and 2.063 higher fluorescence than ICG at t0. In PBS, ICG retained 0.753 of its initial fluorescence while MCyD-I actually increased to 29.863 and SCyD-I retained 20.833 of initial ICG fluorescence in PBS.
Protocol (for reference only)
Cell Experiment
Cell lines Caco-2 cells
Preparation method The cells were then preincubated for 30 min without Nos solution+permeation enhancer CH or CP and then incubated for 120 min at 37 ℃ with the Nos solution (50 mg/ml)+permeation enhancer CH or CP.
Concentrations 50 mg/ml
Incubation time 2 h
Animal Experiment
Animal models pig
Formulation 10-mL solution composed of 25% water and 75% PEG400
Dosages 5 mg/kg
Administration bolus infusions
Chemical Information
Molecular Weight 1451.29
Formula C50H84Na2O41S2
CAS Number 182410-00-0
Solubility (25°C) Water > 120 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Valentino J Stella, et al. Sulfobutylether-β-cyclodextrin

[2] Farouk Semcheddine, et al. Effects of the Preparation Method on the Formation of True Nimodipine SBE-β-CD/HP-β-CD Inclusion Complexes and Their Dissolution Rates Enhancement

[3] Valentino J Stella, et al. Cyclodextrins

[4] Mamoru Fukuda, et al. Int J Pharm. Influence of sulfobutyl ether beta-cyclodextrin on the dissolution properties of a poorly soluble drug from extrudates prepared by hot-melt extrusion

[5] V Zia, et al. Effect of cyclodextrin charge on complexation of neutral and charged substrates: comparison of (SBE)7M-beta-CD to HP-beta-CD

Você também pode estar interessado nos seguintes produtos:



Referência
Descrição
Cond.
Price Bef. VAT
M2114-10mg
 10mg 
M2114-50mg
 50mg 
HY-17031-1g
 1g